Table 1 The optimal timing of hAFSC administration for eliciting significant therapeutic effect in LPS-induced neonatal sepsis
Timing of hAFSC injection | Survival rate (%) | N | p value |
|---|---|---|---|
LPS only | 50.0 | 40 | – |
− 3 h | 78.5 | 28 | 0.015* |
0 | 56.3 | 16 | 0.67 |
+ 3 h | 50.0 | 18 | 1.00 |
+ 24 h | 50.0 | 20 | 1.00 |